Cargando…
Cre Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40
Gene therapy has been shown to be a feasible approach to treat inherited disorders in vivo. Among the currently used viral vector systems, adeno-associated virus (AAV) vectors are the most advanced and have been applied in patients successfully. An important drawback of non-integrating AAV vectors i...
Autores principales: | Shi, Xiaoxia, Ykema, Matthew Ryan, Hazenoot, Jaco, ten Bloemendaal, Lysbeth, Mancini, Irene, Odijk, Machteld, de Haan, Peter, Bosma, Piter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948228/ https://www.ncbi.nlm.nih.gov/pubmed/29766030 http://dx.doi.org/10.1016/j.omtm.2018.02.010 |
Ejemplares similares
-
Low efficacy of recombinant SV40 in Ugt1a1(-/-) mice with severe inherited hyperbilirubinemia
por: Shi, Xiaoxia, et al.
Publicado: (2021) -
Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies
por: Toscano, Miguel G., et al.
Publicado: (2017) -
Adeno-Associated Viral Vector Serotype 5 Poorly Transduces Liver in Rat Models
por: Montenegro-Miranda, Paula S., et al.
Publicado: (2013) -
Reduced spontaneous itch in mouse models of cholestasis
por: Langedijk, Jacqueline, et al.
Publicado: (2021) -
Expression of Cre recombinase in dopaminoceptive neurons
por: Lemberger, Thomas, et al.
Publicado: (2007)